GREGORY WEAVER - 13 Mar 2025 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role: Chief Financial Officer
Signature: /s/ Vipin Garg as Attorney-in Fact
Issuer symbol: ALT
Transactions as of: 13 Mar 2025
Transactions value $: $51,996
Form type: 4
Filing time: 14 Mar 2025, 07:27:34 UTC
Previous filing: 12 Nov 2024
Next filing: 03 Oct 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALT	Common Stock, par value $0.0001	Purchase	$51,996	+10,000		$5.2	10,000	13 Mar 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.1950 to $5.1997, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.1950 to $5.1997, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.